default author photo

Pamela Soliman

affiliation not provided to SSRN

SCHOLARLY PAPERS

5

DOWNLOADS

275

TOTAL CITATIONS

0

Scholarly Papers (5)

1.

Perioperative Outcomes in Gynecologic Pelvic Exenteration Before and after Implementation of an Enhanced Recovery after Surgery Program

Number of pages: 29 Posted: 04 Jul 2024
University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine
Downloads 126 (572,948)

Abstract:

Loading...

Enhanced Recovery After Surgery, pelvic exenteration, gynecologic surgery, surgical outcomes

2.

Oral cyclophosphamide combined with bevacizumab in recurrent heavily pretreated ovarian cancer

Number of pages: 22 Posted: 06 Nov 2025
affiliation not provided to SSRN, McGovern Medical School at UTHealth, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, affiliation not provided to SSRN, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine and affiliation not provided to SSRN
Downloads 47 (1,170,409)

Abstract:

Loading...

Recurrent ovarian cancer, High-grade serous ovarian cancer (HGSOC), Platinum resistant ovarian cancer (PROC), Cyclophosphamide, Bevacizumab.

3.

Hormonal Therapy in Low-Grade Endometrial Stromal Sarcoma; What is the Current Standard of Care?

Number of pages: 25 Posted: 30 May 2024
affiliation not provided to SSRN, University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, University of Texas at Houston - MD Anderson Cancer Center and affiliation not provided to SSRN
Downloads 44 (1,133,231)

Abstract:

Loading...

Endometrial Stromal Sarcoma, low-grade ESS, uterine sarcoma, hormonal therapy, Megace, Letrozole

4.

Clear cell carcinoma of cervix and vagina: a review of 63 cases in the post-DES era

Number of pages: 23 Posted: 06 Nov 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 31 (1,304,549)

Abstract:

Loading...

clear cell carcinoma, cervical carcinoma, vaginal carcinoma, post-DES era, cCCC, vCCC

5.

Bevacizumab Beyond Progression: Impact of Subsequent Bevacizumab Re-Treatment in Patients with Ovarian, Fallopian Tube, and Peritoneal Cancer after Progression

Number of pages: 25 Posted: 08 Oct 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, University of Colorado Anschutz Medical Campus, University of Texas at Houston - MD Anderson Cancer Center, Duke University - Medical Center, Columbia University College of Physicians and Surgeons, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, affiliation not provided to SSRN, Duke University and University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine
Downloads 27 (1,359,097)

Abstract:

Loading...

ovarian cancer, fallopian tube cancer, bevacizumab, angiogenesis inhibitors